4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-005577
EVP, CHIEF FINANCIAL OFFICER sold 772 shares at $24.67 ($19,045)
- EVP, CHIEF FINANCIAL OFFICER acquired 1,353 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-02-23 | Option exercise | +1,353 | 21,839 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-02-26 | Sale | −772 | $24.67 | $19,045 | 21,067 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-02-23 | Option exercise · Restricted Stock Units | −1,353 | 1,353 | D | ||
| Open-market sales · 772 sh · avg $24.67 · $19,045 | |||||||
Loading xslF345X05/form4-02272024_110237.xml…